Gujarat Kidney And Super Speciality IPO Date, Review, Price and Key Information

Gujarat Kidney And Super Speciality Limited IPO is fully book build issue and total IPO size is ₹[] crores. The total offering consists of 2.2 crore shares.

The dates for the Gujarat Kidney And Super Speciality Limited IPO have not been announced yet. The allotment process is expected to be finalized by [.].

The Gujarat Kidney And Super Speciality Limited IPO is scheduled to list on NSE, BSE, with a listing date of [.]. The price band for the Gujarat Kidney And Super Speciality Limited IPO has not been announced yet.

Registrar for this IPO is Mufg Intime India Private Limited and lead managers for Gujarat Kidney And Super Speciality Limited IPO are Nirbhay Capital Services Private Limited.

IPO Schedule

IPO Open Date	-
IPO Close Date	-
IPO Allotment Date	-
Refund Initiation	-
Share credit in Demat	-
Listing Date	-

Key Details

Price Band	TBA
Lot Size	TBA
Face Value	₹2 Per Equity Share
Total Issue Size	22,000,000 Shares
Fresh Issue	22,000,000 Shares
Issue Type	Fresh Issue
Listing At	NSE, BSE

Share Reservation

Investor Category	Shares Offered
QIB	75%
Retail	10%
NII/HNI	15%

About Gujarat Kidney And Super Speciality Limited Company

Parekhs Hospital is a regional healthcare provider in central Gujarat, operating a chain of multispeciality hospitals focused on secondary and tertiary care. As of March 20, 2025, it operates six multispeciality hospitals and three pharmacies with a total bed capacity of 400 beds, approved bed capacity of 355 beds and operational bed capacity of 250 beds.

Key specialities include General Medicine, Surgery, Laparoscopic Surgery, and others, with super-specialities such as Urology, Cardiology, and Nephrology. Parekhs Hospital has received awards including the Eminence Certificate for Best Joint Replacement Hospital and the Certificate of Appreciation Best Hospital of the year.

Financial highlights show a revenue from operations and other income of ₹26.61 crore in 2024, with a profit after tax of ₹2.70 crore. The company is in the process of being acquired for an aggregate purchase consideration of up to ₹79 crore, including a non-compete fee of ₹1 crore. Equity capital is ₹25.50 Lakh. Parekhs Hospital focuses on providing quality, affordable healthcare services.

Gujarat Kidney And Super Speciality Limited Financial Details

Period Ended	30 Sep 2024	31 Mar 2025	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	366.46	205.26	38.67	38.78
Revenue	186.71		47.74	0.00	0.79
Profit After Tax	56.31		17.14	-0.06	1.00
Net Worth	206.14	108.04	3.70	3.77
Reserves and Surplus	188.47	106.04	1.70	1.77
Total Borrowing	36.87	19.44	0.00	0.00

₹ In Crore

Key Performance Indicator

Basic EPS (in ₹)	Return on Net Worth (RoNW)	Net Asset Value (NAV)	Debt-Equity Ratio	Return on Equity (ROE)	Return on Capital Employed (ROCE)
1.24	30.03%	4.13

Offer Objectives

The document outlines details regarding the upcoming IPO, focusing on the utilization of net proceeds and lock-in periods for various stakeholders.

Promoter Contribution and Lock-in: Promoters have committed to a contribution constituting 20% of the post-issue equity. These shares are subject to lock-in as per SEBI ICDR Regulations and cannot be encumbered until the lock-in period expires.

Lock-in Periods: The entire pre-issue capital is locked in for six months from the allotment date, with exceptions for VCFs and AIFs under specific conditions. Anchor investors face lock-in periods of 90 days for 50% of allotted shares and 30 days for the remaining 50%.

Issue Objectives: The company intends to utilize the net proceeds from the IPO to acquire "Parekhs Hospital Private Limited" in Ahmedabad, partly fund the "Ashwini Medical Centre" acquisition, establish a women's healthcare hospital in Vadodara, procure robotics equipment for Gujarat Kidney & Super Speciality hospital, repay borrowings, and fund inorganic growth. Total investment in Parekhs Hospital Private Limited is estimated to be ₹ 79 Crore (inclusive of non-compete fees of ₹ 1 Crore) of which ₹ 77 Crore will be from Net Proceeds.

Fund Allocation and Implementation: A significant portion of the funds is earmarked for the Parekhs Hospital acquisition (₹ 77 Crore) and capital expenditure for the new Vadodara hospital. Inorganic growth and general corporate purposes are capped at 35% and 25% of the gross proceeds, respectively.

Acquisition Rationale: The Parekhs Hospital acquisition aims to leverage an established healthcare facility in Ahmedabad, enhancing the company's market presence and service offerings.